Drug Information

Drug General Information
Drug ID
D08ALK
Former ID
DNC000439
Drug Name
Cisatracurium
Synonyms
Cisatracurium Besylate; Cisatracurium Besylate Preservative Free; Nimbex; Nimbex Preservative Free
Drug Type
Small molecular drug
Indication Muscle relaxant [ICD10:N39.3, N39.4, R32] Approved [551871]
Discovery agent Phase 4 [525283]
Company
Abbvie Inc
Structure
Download
2D MOL

3D MOL
Formula
C65H82N2O18S2
Canonical SMILES
C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(<br />=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)<br />OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S<br />(=O)(=O)[O-]
InChI
1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1
InChIKey
XXZSQOVSEBAPGS-DONVQRBFSA-L
CAS Number
CAS 96946-42-8
PubChem Compound ID
62886
PubChem Substance ID
7847824, 7978533, 8188345, 11113043, 12014680, 43119947, 46506666, 49835824, 50065421, 56268482, 57314899, 75324009, 103770624, 104326905, 117384760, 124403636, 126607198, 126665888, 134222121, 134337515, 134339864, 135019778, 137006710, 143504269, 160963910, 162181993, 164831244, 175266594, 175269717, 175612222, 198957787, 210274894, 210280529, 224405114, 226425863, 252215160, 252359546
SuperDrug ATC ID
M03AC11
SuperDrug CAS ID
cas=096946428
Target and Pathway
Target(s) Cholinergic receptor Target Info Antagonist [538073]
Neuronal acetylcholinereceptor subunit alpha-2 Target Info Antagonist [536781], [537286]
KEGG Pathway Neuroactive ligand-receptor interaction
PANTHER Pathway Nicotinic acetylcholine receptor signaling pathway
Reactome Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
Highly calcium permeable nicotinic acetylcholine receptors
WikiPathways Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
References
Ref 525283ClinicalTrials.gov (NCT02518789) Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 536781Synergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors. Anesth Analg. 2008 Aug;107(2):525-33.
Ref 537286Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology. 2009 Jun;110(6):1244-52.
Ref 538073Bradycardia produced by pyridostigmine and physostigmine. Can J Anaesth. 1997 Dec;44(12):1286-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.